Phase III, Randomized, Placebo-Controlled Trial of CC-486 (Oral Azacitidine) in Patients With Lower-Risk Myelodysplastic Syndromes

  1. Garcia-Manero, G.
  2. Santini, V.
  3. Almeida, A.
  4. Platzbecker, U.
  5. Jonasova, A.
  6. Silverman, L.R.
  7. Falantes, J.
  8. Reda, G.
  9. Buccisano, F.
  10. Fenaux, P.
  11. Buckstein, R.
  12. Diez Campelo, M.
  13. Larsen, S.
  14. Valcarcel, D.
  15. Vyas, P.
  16. Giai, V.
  17. Olíva, E.N.
  18. Shortt, J.
  19. Niederwieser, D.
  20. Mittelman, M.
  21. Fianchi, L.
  22. La Torre, I.
  23. Zhong, J.
  24. Laille, E.
  25. Lopes de Menezes, D.
  26. Skikne, B.
  27. Beach, C.L.
  28. Giagounidis, A.
  29. Show all authors +
Journal:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology

ISSN: 1527-7755

Year of publication: 2021

Volume: 39

Issue: 13

Pages: 1426-1436

Type: Article

DOI: 10.1200/JCO.20.02619 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals